Drug news
Brilinta/Brilique(AstraZeneca) study in Peripheral Vascular Disease
Astra Zeneca will commence a new study called EUCLID of Brilinta/Brilique(ticagrelor) to compare twice daily dosing of Brilinta/Brilique with once dosing daily of now generic Plavix (clopidogrel) in 11 500 patients with Peripheral Vascular Disease.